SCHEMBL27720385

SCHEMBL27720385

O=C(Nc1cnc(Cl)c(NC(=O)c2ccccc2)c1)c1cccc(F)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ3 O43525 3/20 0.67
KCNQ2 O43526 3/20 0.67
KCNQ5 Q9NR82 1/20 0.67
KCNE1 P15382 1/20 0.64
KCNQ1 P51787 1/20 0.64
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
KCNK3 O14649 2/20 0.61
RAB9A P51151 7/20 0.57
NPC1 O15118 6/20 0.57
HPGD P15428 1/20 0.57
ALDH1A1 P00352 2/20 0.54
PKM P14618 1/20 0.54
TSHR P16473 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.53
KCNK9 Q9NPC2 1/20 0.52
KDM4E B2RXH2 1/20 0.51
CASP3 P42574 1/20 0.51
SENP7 Q9BQF6 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopropane SCHEMBL27699785 0.96 KCNQ3 (0.62) KCNQ3KCNQ2KCNQ5KCNE1KCNQ1
SCHEMBL27720433 0.88 MEN1 (0.64) KCNQ3KCNQ2KCNQ5KCNE1KCNQ1
SCHEMBL27720393 0.85 MEN1 (0.61) KCNQ3KCNQ2KCNQ5KCNE1KCNQ1
SCHEMBL27720419 0.85 KMT2A (0.64) KCNQ3KCNQ2MEN1KMT2AKCNK3
SCHEMBL27699760 0.84 KCNQ3 (0.53) KCNQ3KCNQ2KCNQ5KCNE1KCNQ1
Cyclopropane SCHEMBL27720374 0.82 MEN1 (0.57) KCNQ3KCNQ2KCNQ5KCNE1KCNQ1
SCHEMBL27720425 0.82 KCNQ3 (0.66) KCNQ3KCNQ2MEN1KMT2AKCNK3
SCHEMBL27720391 0.82 MAPK14 (0.55) KCNQ3KCNQ2KCNK3HPGDALDH1A1
SCHEMBL4166586 0.82 KCNQ3 (0.45) KCNQ3KCNQ2KCNQ5KCNE1KCNQ1
SCHEMBL27720436 0.81 SERPINE1 (0.51) KCNQ3KCNQ2KCNQ5KCNE1KCNQ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101128454-A Pyridine carboxamide derivatives for use as anticancer agents ASTRAZENECA AB (SE) 2008-02-20 CN disclosed